This discrepancy stems from inconclusive findings with regard to assessing various types of PON1 activity across diverse studies, limited sample sizes, variations in the severity of obesity under investigation, and failure to account for the potential impacts of genetic polymorphisms on PON1 activity [25,26]. The gene discussed is PON1; the disease is obesity due to melanocortin 4 receptor deficiency.